For help on how to get the results you want, see our search tips.
6 results
Medicine type
Conditional approval Remove Conditional approval filter
Exceptional circumstances Remove Exceptional circumstances filter
Biosimilar Remove Biosimilar filter
Additional monitoring Remove Additional monitoring filter
Generic Remove Generic filter
Medicine
Paediatric investigation plans Remove Paediatric investigation plans filter
Direct healthcare professional communication Remove Direct healthcare professional communication filter
Summaries of opinion Remove Summaries of opinion filter
Application type
Initial authorisation Remove Initial authorisation filter
-
List item
Summary of opinion: Lextemy
bevacizumab, opinion date: 25/02/2021, Positive, Last updated: 26/02/2021 -
List item
Summary of opinion: Libmyris
adalimumab, opinion date: 16/09/2021, Positive, Last updated: 17/09/2021 -
List item
Summary of opinion: Hukyndra
adalimumab, opinion date: 16/09/2021, Positive, Last updated: 17/09/2021 -
List item
Summary of opinion: Imoxat
imidacloprid, moxidectin, opinion date: 07/10/2021, Positive, Last updated: 08/10/2021 -
List item
Summary of opinion: Sitagliptin SUN
sitagliptin fumarate, opinion date: 14/10/2021, Positive, Last updated: 15/10/2021 -
List item
Summary of opinion: Rybrevant
amivantamab, opinion date: 14/10/2021, Positive, Last updated: 15/10/2021